Company Profile
Abeona Therapeutics Stock Price, News & Analysis
- Ticker:
- ABEO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Abeona Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
5.72 USD (-0.52%)
Close
Last updated: June 23, 2026 at 00:00
326.01M USD
Market cap
Why the stock is moving
ABEO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Abeona Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Abeona Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Abeona Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Abeona Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
Source: Abeona Therapeutics
- 02
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
Source: Abeona Therapeutics
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Abeona Therapeutics (ABEO)?
Abeona Therapeutics (ABEO) most recently closed at 5.72 USD, a -0.52% move versus the previous session.
What is the market cap of Abeona Therapeutics (ABEO)?
Abeona Therapeutics currently has a market capitalization of 326.01M USD on BioPharmSignal.
What does Abeona Therapeutics do?
Abeona Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ABEO stock listed?
Abeona Therapeutics (ABEO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Abeona Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Abeona?
Abeona Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Abeona Therapeutics targeting with Abeona?
Abeona Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Abeona Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.